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release by phosphorylating different protein substrates. Synaptophysin, a synaptic vesicle protein, is phosphorylated by Src in vitro but we did not detect significant tyrosine phosphorylation of synaptophysin in PC12 cells. 3 SFK inhibitor-treatment causes a reduction of tyrosine phosphorylation of Pyk2 and paxillin, which are involved in regulation of the actin cytosketeton, and leads to a dramatic change in morphology of PC12 cells. Interestingly, inhibition of actin polymerization with Cytochalasin D and Latrunculin A enhanced Ca 2+ -dependent neurotransmitter release from PC12 cells and cultured rat cerebellar granule cells. It is thus possible that Src kinase suppresses neurotransmitter release by regulating cytoskeletal dynamics. The protein substrate essential for the JAK2-mediated inhibition has not yet been identified. The activity of Src and JAK2 are regulated through tyrosine phosphorylation. Furthermore, JAK2 phosphorylates tyrosine residues in the cytokine receptor, which can recruit and activate Src through the binding of an SH2 domain to phosphotyrosine.
5 Thus, it is also possible that JAK and Src mediate inhibition via common signal transduction pathways.
Many kinds of receptor tyrosine kinases are expressed in brain and the activation of these receptors stimulates neurotransmitter release in a tyrosine kinase-dependent manner.
11 Downstream signaling pathways including PI-3 kinase, MAP kinase and PLC are essential for positive regulation by receptor tyrosine kinases. It is quite interesting that the receptor tyrosine kinases and the non-receptor tyrosine kinases have opposite roles at presynaptic sites. But it is also a mystery since the downstream signaling pathways of receptor tyrosine kinases are also activated by JAK2-associated cytokine receptors. Furthermore, receptor tyrosine kinases can activate Src in some preparations. Many new questions must now be addressed in future studies to understand the molecular mechanisms and physiological roles of Src-and JAK2-mediated negative regulation of presynaptic functions in the nervous system. 3 have provided further evidence for an association between the DRD4 exon III 7 repeat allele and higher scores in Novelty Seeking, a number of studies failed to replicate the initial findings. 4 A recently identified single nucleotide polymorphism (−521C/T) in the promoter region of the DRD4 gene, 5 which is associated with variation in transcriptional efficiency, has also been reported to affect individual differences in Novelty Seeking. 5, 6 In these studies, the presence of the T allele (resulting in reduced transcriptional efficiency) was associated with significantly lower scores in Novelty Seeking. The aim of the present study was an investigation whether both the DRD4 exon III and the DRD4 −521C/T polymorphism are associated with individual differences in Novelty Seeking.
M
Two hundred and seventy-six unrelated healthy volunteers of German ethnicity (205 women and 71 men; mean age: 21.9 ± 3.9 years, age range: 18-41 years) completed the German version of the Tridimensional Personality Questionnaire, 7 and individual DRD4 exon III genotypes were determined as previously described. 1 For determination of DRD4 −521 C/T genotypes, oligonucleotide primers (DRD4/627F, 5Ј-CGGGGGCTGAGCACCAGAGGCTGCT and DRD4/343R, 5Ј-GCATCGACGCCAGCGCCATCCTACC) were used to generate a 285-bp fragment. PCR amplification was performed for 37 cycles at 60°C (45 s), 72°C (45 s), and 95°C (45 s) in a final volume of 25 l containing 100 ng of genomic DNA, 20 pmol of each primer, 200 M of each dNTP, 1.0 mM MgCl 2 , 50 mM KCl, 10 mM Tris HCl (pH 8.3 at 25°C), 0.025 mg ml −1 BSA, 0.025% Tween 20, and 0.5 U of Taq DNA polymerase (Eurogentec, Seraing, Belgium). PCR products were analysed by FspI digestion followed by separation of the resulting fragments on agarose gels containing 2% ethidium bromide next to a DNA size standard. The two polymorphisms were in significant linkage disequilibrium (DЈ = 0.20, P = 0.005; calculation performed with 2LD, http://www.iop.kcl.ac.uk/IoP/ Departments/Psych Med/GEpiBSt/software.stm).
Analysis of variance showed that individuals with and without the DRD4 exon III 7 repeat did not differ in their Novelty Seeking scores (F 1,274 = 1.28, P = 0.26; for raw mean scores ± SD see Table 1 ). Similar results were obtained when comparing the most frequent DRD4 exon III genotypes (24 vs 44 vs 47 genotype: F 2,220 = 2.35, P = 0.10) With regard to a potential association between the DRD4 −521C/T polymorphism and Novelty Seeking, analyses of variance showed that individuals with distinct −521C/T genotypes (CC vs CT vs TT) did not differ in their Novelty Seeking scores (F 2,273 = 0.31, P = 0.74). Furthermore, no significant differences emerged when comparing CC vs CT & TT genotypes (F 1,275 = 0.02, P = 0.89). This grouping was based on the functional role of the T allele and on the findings of Ronai et al. 6 Finally, no gender-specific associations between −521C/T and Novelty Seeking emerged as might be expected from previous results 6 (data not shown).
In subsequent analyses based on DRD4 exon III × −521C/T haplotypes, there were no significant differences in Novelty Seeking between groups based on haplotypes, neither when constructing (exon III 7 repeat absent/present) × (−521 CC/CT/TT) haplotypes nor when constructing (exon III 24/44/47 genotypes) × (−521 CC/CT/TT) haplotypes (one-way analyses of variance, all P Ͼ 0.05).
In conclusion, our data do not provide evidence for associations between the two DRD4 polymorphisms and Novelty Seeking. Several reasons may account for our failure to replicate the reported associations. First, our sample may not have provided sufficient power to detect an association between the DRD4 polymorphisms and Novelty Seeking. However, several previous studies reporting associations between Novelty Seeking and DRD4 exon III, 1, 3 or −521C/T 5, 6 have been based on samples of much smaller size. Therefore, we should have been able to detect associations between the two DRD4 polymorphisms and Novelty Seeking. Second, the possibility of false negative results due to stratification effects cannot be completely ruled out as a source of error in our sample of unrelated individuals, even though all participants were of German ethnicity and there were no influences of age and gender (data not shown). Finally, developmental factors and compensatory interactions with other biological mechanisms may account for the presence or absence of a phenotypic effect of a given functional polymorphism. Although functional differences have been reported between DRD4 exon III variants, 8 and between DRD4 −521C/T variants, 5 respectively, the pathways in which these functional differences affect behavioral variation remain to be fully understood. 1,2 Evidence against these findings 3, 4 makes the association controversial. In 5-HTTLPR polymorphism, a 44-bp insertion or deletion, the transcriptional activity of the short (S) variant is half that of the long (L) variant, leading to a 50% decrease in 5-HTT expression and 5-HT uptake.
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